home / stock / ebs / ebs news


EBS News and Press, Emergent Biosolutions Inc. From 06/09/22

Stock Information

Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com

Menu

EBS EBS Quote EBS Short EBS News EBS Articles EBS Message Board
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...

EBS - 7 Monkeypox Stocks That May Take Off in Q2

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Once a problem confined to just one continent, Monkeypox is spreading and threatens to become a global issue. Since the United Kingdom first reported a confirmed Monkeypox case on May 7, many more cases have been reported ...

EBS - Johnson & Johnson terminating COVID-19 vaccine contract with Emergent - WSJ

Johnson & Johnson (NYSE:JNJ) has notified Emergent BioSolutions (NYSE:EBS) it is terminating its supply deal with the contract manufacturer, with the pharma giant accusing Emergent of breaching a contract, The Wall Street Journal reported. Earlier on Monday, Emergent (EBS) accused J&J...

EBS - Johnson & Johnson breached vaccine contract, Emergent says

Contract manufacturer Emergent BioSolutions (NYSE:EBS) disclosed on Monday that the company notified Johnson & Johnson (JNJ) of a material breach of a contract between the two parties to produce the pharma giant’s COVID-19 shot. Janssen Pharmaceuticals of J&J (JNJ) and Emergent...

EBS - Chimerix: Down But Not Out

Today, we revisit an interesting small-cap concern called Chimerix that trades for around two bucks a share, and under cash value. The company recently announced a deal to sell off its one approved drug for over $200 million, which was received negatively by the market. Chimerix w...

EBS - EMA discussing extending Bavarian Nordic smallpox vaccine indication for monkeypox

Imvanex, Bavarian Nordic's (OTCPK:BVNKF) (OTCPK:BVNRY) smallpox vaccine, could receive an additional indication for the prevention of monkeypox, according to a top European Medicines Agency official. During a Thursday press conference, Marco Cavaleri, the EMA's head of biological heath threat...

EBS - Top Penny Stocks To Watch As Monkeypox Cases Rise

The latest outbreak of monkeypox has some scratching their heads. What more can 2022 bring to the market? We’ve seen a stock market crash, the hopeful recovery from COVID-19, record inflation, rising rates, and now this. But it has placed some penny stocks in focus. On Wednes...

EBS - Cowen believes widespread monkeypox outbreak unlikely, highlights revenue opportunities

Cowen believes a widespread monkeypox outbreak is unlikely, and that existing vaccines and drugs can contain the recent rise in cases. More than 300 suspected and confirmed cases of monkeypox have been reported in May, mostly in Europe. The disease is usually found in Africa. It is usually a ...

EBS - What Stocks To Invest In Now? 4 Biotech Stocks To Know

4 Top Biotech Stocks For Your Watch List This Week For investors eyeing the most active stocks in the stock market , biotech stocks would come to mind. After all, there is a constant flow of clinical development updates coming from the industry day in and day out. Because of thi...

EBS - Emergent BioSolutions: A Top Pick For The Monkeypox Outbreak

Emergent BioSolutions’ stock has spiked up over the past week as a monkeypox outbreak begins to spread to Europe and North America. The company is my Top Pick for monkeypox. Emergent's smallpox vaccine, ACAM2000, is expected to be effective against monkeypox due to its close re...

EBS - Co-Diagnostics extends gains on monkeypox test development

The shares of Co-Diagnostics (NASDAQ:CODX) are trading higher for the third straight session on Friday in solidarity with makers of monkeypox vaccines and therapeutics after molecular diagnostics company announced its contribution to address the virus outbreak. Co-Diagnostics (CODX) said Thur...

Previous 10 Next 10